#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Luc Demangeon Email
VP REGULATORY, QUALITY & CLINICAL . Web App
How to contact Luc Demangeon
Join and see Luc's contact info for free!Current Roles
Employees:
21Revenue:
$5.3MAbout
STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS' SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company's product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS' commercial network in Europe, the Middle East, Asia and Latin America.Web App Address
18 Rue d'HautevilleParis, null
France